127 related articles for article (PubMed ID: 11695810)
1. Successful treatment of a persistent mole with myometrial invasion by direct injection of methotrexate.
Su WH; Wang PH; Chang SP
Eur J Gynaecol Oncol; 2001; 22(4):283-6. PubMed ID: 11695810
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-guided local injection of methotrexate to treat an invasive hydatidiform mole.
Tsukihara S; Harada T; Terakawa N
J Obstet Gynaecol Res; 2004 Jun; 30(3):202-4. PubMed ID: 15210043
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia.
Kizaki S; Hashimoto K; Matsui H; Usui H; Shozu M
Gynecol Oncol; 2015 Dec; 139(3):429-32. PubMed ID: 26456138
[TBL] [Abstract][Full Text] [Related]
4. Sonographic characteristics of post-molar gestational trophoblastic neoplasia at diagnosis and during follow-up, and relationship with methotrexate resistance.
Epstein E; Joneborg U
Ultrasound Obstet Gynecol; 2020 Nov; 56(5):759-765. PubMed ID: 31909527
[TBL] [Abstract][Full Text] [Related]
5. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
7. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
[TBL] [Abstract][Full Text] [Related]
8. Complete hydatidiform mole coexisting with a twin live fetus: clinical course.
Hurteau JA; Roth LM; Schilder JM; Sumners J
Gynecol Oncol; 1997 Jul; 66(1):156-9. PubMed ID: 9234938
[TBL] [Abstract][Full Text] [Related]
9. Successful pregnancy following conservative surgical therapy of an invasive molar gestation.
Rowan SP; Stitely ML; Toffle RC
W V Med J; 2010; 106(3):24-5. PubMed ID: 21736152
[TBL] [Abstract][Full Text] [Related]
10. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
[TBL] [Abstract][Full Text] [Related]
11. Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review.
Nobuhara I; Harada N; Haruta N; Higashiura Y; Watanabe H; Watanabe S; Hisanaga H; Sado T
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):588-593. PubMed ID: 30122584
[TBL] [Abstract][Full Text] [Related]
12. Term delivery of a complete hydatidiform mole with a coexisting living fetus followed by successful treatment of maternal metastatic gestational trophoblastic disease.
Peng HH; Huang KG; Chueh HY; Adlan AS; Chang SD; Lee CL
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):397-400. PubMed ID: 25286799
[TBL] [Abstract][Full Text] [Related]
13. Invasive mole.
Lurain JR; Brewer JI
Semin Oncol; 1982 Jun; 9(2):174-80. PubMed ID: 6289460
[No Abstract] [Full Text] [Related]
14. Doppler study of myometrium in invasive gestational trophoblastic disease.
Oguz S; Sargin A; Aytan H; Kelekci S; Dumanli H
Int J Gynecol Cancer; 2004; 14(5):972-9. PubMed ID: 15361211
[TBL] [Abstract][Full Text] [Related]
15. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
Sasaki S; Sasaki Y; Iino K
J Reprod Med; 2010; 55(7-8):317-20. PubMed ID: 20795345
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of hydatidiform mole with the Milan-Markley helix.
Milan AR
Obstet Gynecol; 1976 Sep; 48(3):328-35. PubMed ID: 181703
[TBL] [Abstract][Full Text] [Related]
17. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced dynamic MR imaging of postmolar gestational trophoblastic disease.
Yamashita Y; Torashima M; Takahashi M; Mizutani H; Miyazaki K; Matsuura K; Okamura H
Acta Radiol; 1995 Mar; 36(2):188-92. PubMed ID: 7536014
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
[TBL] [Abstract][Full Text] [Related]
20. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
